1. Home
  2. AVDL
  3. AVDL News

Latest Avadel Pharmaceuticals plc (AVDL) News on March 9, 2025

AVDL

Argus Research

2 days ago

Daily – Vickers Top Insider Picks for 03/07/2025

AVDL

Argus Research

3 days ago

Daily – Vickers Top Insider Picks for 03/06/2025

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
AVDL

GlobeNewswire

4 days ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

AVDL

Argus Research

4 days ago

Daily – Vickers Top Insider Picks for 03/05/2025

AVDL

MT Newswires

5 days ago

Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating

AVDL

Argus Research

5 days ago

Daily – Vickers Top Insider Picks for 03/04/2025

Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
AVDL

Simply Wall St.

5 days ago

Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

AVDL

GuruFocus.com

6 days ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

AVDL

Associated Press Finance

6 days ago

Avadel: Q4 Earnings Snapshot

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
AVDL

GlobeNewswire

6 days ago

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

AVDL

Argus Research

6 days ago

Daily – Vickers Top Insider Picks for 03/03/2025

Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now?
AVDL

Insider Monkey

8 days ago

Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now?

AVDL

GuruFocus.com

9 days ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Look For

AVDL

Argus Research

9 days ago

Daily – Vickers Top Insider Picks for 02/28/2025

AVDL

Argus Research

10 days ago

Daily – Vickers Top Insider Picks for 02/27/2025

AVDL

Argus Research

11 days ago

Daily – Vickers Top Insider Picks for 02/26/2025

AVDL

Argus Research

12 days ago

Daily – Vickers Top Insider Picks for 02/25/2025

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3
AVDL

GlobeNewswire

13 days ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
AVDL

GlobeNewswire

13 days ago

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales

AVDL

Argus Research

13 days ago

Daily – Vickers Top Insider Picks for 02/24/2025

AVDL

Argus Research

16 days ago

Daily – Vickers Top Insider Picks for 02/21/2025

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
AVDL

GlobeNewswire

17 days ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

AVDL

Argus Research

17 days ago

Daily – Vickers Top Insider Picks for 02/20/2025

AVDL

Argus Research

18 days ago

Daily – Vickers Top Insider Picks for 02/19/2025

AVDL

Argus Research

19 days ago

Daily – Vickers Top Insider Picks for 02/18/2025

AVDL

Argus Research

23 days ago

Daily – Vickers Top Insider Picks for 02/14/2025

AVDL

Argus Research

24 days ago

Daily – Vickers Top Insider Picks for 02/13/2025

AVDL

Argus Research

25 days ago

Daily – Vickers Top Insider Picks for 02/12/2025

AVDL

MT Newswires

a month ago

Deutsche Bank Initiates Coverage on Avadel Pharmaceuticals With Buy Rating, $12 Price Target

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 02/11/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 02/10/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 02/07/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 02/06/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 02/05/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 02/04/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 02/03/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 01/31/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 01/30/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 01/29/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 01/28/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 01/27/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 01/24/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 01/23/2025

AVDL

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 01/23/2025

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
AVDL

GlobeNewswire

2 months ago

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 01/22/2025

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 01/21/2025

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 01/17/2025

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 01/16/2025

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 01/15/2025

AVDL

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 01/15/2025

AVDL

MT Newswires

2 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $14 From $22, Maintains Buy Rating

AVDL

MT Newswires

2 months ago

Needham Adjusts Avadel Pharmaceuticals' Price Target to $19 From $22, Keeps Buy Rating

AVDL

GuruFocus.com

2 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

AVDL

MT Newswires

2 months ago

Avadel Pharmaceuticals Preliminary Q4 Net Product Revenue Rises; 2025 Outlook Set; Shares Fall After Hours

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
AVDL

GlobeNewswire

2 months ago

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect
AVDL

GuruFocus.com

2 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
AVDL

GlobeNewswire

2 months ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
AVDL

GlobeNewswire

2 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8

Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock
AVDL

Simply Wall St.

3 months ago

Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy
AVDL

GlobeNewswire

3 months ago

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

AVDL

MT Newswires

4 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $22 From $25, Maintains Buy Rating

Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
AVDL

Simply Wall St.

4 months ago

Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
AVDL

GlobeNewswire

4 months ago

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

AVDL

GuruFocus.com

4 months ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ...

AVDL

MT Newswires

4 months ago

Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises

AVDL

Associated Press Finance

4 months ago

Avadel: Q3 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results
AVDL

GlobeNewswire

4 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings
AVDL

GuruFocus.com

4 months ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12
AVDL

GlobeNewswire

4 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle
AVDL

Pharmaceutical Technology

4 months ago

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term
AVDL

Simply Wall St.

4 months ago

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation
AVDL

GlobeNewswire

4 months ago

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances
AVDL

GlobeNewswire

4 months ago

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances

Avadel wins FDA approval for narcolepsy drug Lumryz in children
AVDL

Pharmaceutical Technology

5 months ago

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz
AVDL

Zacks

5 months ago

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz

AVDL

MT Newswires

5 months ago

Avadel Pharmaceuticals Gets FDA Approval for Lumryz to Treat Cataplexy in Narcolepsy Patients

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy
AVDL

GlobeNewswire

5 months ago

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

AVDL

GuruFocus.com

5 months ago

Avadel Pharmaceuticals PLC (AVDL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent
AVDL

GlobeNewswire

5 months ago

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)
AVDL

GlobeNewswire

6 months ago

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)

AVDL

MT Newswires

6 months ago

Sector Update: Health Care

AVDL

MT Newswires

6 months ago

Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
AVDL

GlobeNewswire

6 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Avadel Pharmaceuticals plc (AVDL): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
AVDL

Insider Monkey

6 months ago

Avadel Pharmaceuticals plc (AVDL): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension
AVDL

GlobeNewswire

7 months ago

Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension

AVDL

MT Newswires

7 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $25 From $23, Maintains Buy Rating

AVDL

MT Newswires

7 months ago

Avadel Pharmaceuticals Narrows Q2 Net Loss as Product Revenue Climbs

Are Medical Stocks Lagging DaVita (DVA) This Year?
AVDL

Zacks

7 months ago

Are Medical Stocks Lagging DaVita (DVA) This Year?

AVDL

Associated Press Finance

7 months ago

Avadel: Q2 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results
AVDL

GlobeNewswire

7 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82
AVDL

Investor's Business Daily

7 months ago

Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82

Does Avadel (AVDL) Have the Potential to Rally 43.6% as Wall Street Analysts Expect?
AVDL

Zacks

7 months ago

Does Avadel (AVDL) Have the Potential to Rally 43.6% as Wall Street Analysts Expect?

Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8
AVDL

GlobeNewswire

7 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8

Avadel announces first subject dosing in Phase III idiopathic hypersomnia trial
AVDL

Clinical Trials Arena

7 months ago

Avadel announces first subject dosing in Phase III idiopathic hypersomnia trial

Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
AVDL

GlobeNewswire

7 months ago

Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

AVDL

MT Newswires

8 months ago

Avadel Pharmaceuticals to Join Russell 3000 Index Monday; Shares Rise After Hours

Avadel Pharmaceuticals to Join Russell 3000® Index
AVDL

GlobeNewswire

8 months ago

Avadel Pharmaceuticals to Join Russell 3000® Index

Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
AVDL

Zacks

9 months ago

Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?

VanEck Semiconductor ETF Is Riskier Than You Think
AVDL

Motley Fool

9 months ago

VanEck Semiconductor ETF Is Riskier Than You Think

Share on Social Networks: